Clinical trial
Fludarabine With or Without Cyclophosphamide in Treating Patients With Advanced…
NCT00276848 · German CLL Study Group, Other · Completed
Key facts
| NCT number | NCT00276848 |
|---|---|
| Title | Fludarabine With or Without Cyclophosphamide in Treating Patients With Advanced Chronic Lymphocytic Leukemia |
| Official title | Fludarabine Versus Fludarabine Plus Cyclophosphamide in First Line Therapy of Younger Patients (Up to 65 Years) With Advanced Chronic Lymphocytic Leukemia (CLL) |
| Lead sponsor | German CLL Study Group, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Lymphocytic Leukemia |
| Intervention type | Drug |
| Interventions | Fludarabine plus Cyclophosphamide, Fludarabine |
| Enrollment | 375 |
| Start date | Jul 1, 1999 |
| Primary completion | Jul 1, 2003 |
| Completion | Jul 1, 2007 |
| First posted | Jan 13, 2006 |
| Last update posted | May 23, 2019 |
| Countries | Austria, Germany |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: